Adil Daud, M.D., is an expert in treatment and drug development for melanoma, with a particular focus on targeted therapies and immunotherapies. The director of the Melanoma Program at the UCSF Helen Diller Family Comphrensive Cancer Center, he completed a fellowship in medical oncology was at the Memorial Sloan Kettering Cancer Center and was a faculty member at the Moffitt Cancer Center in Tampa, Florida. Over the last decade, he has been involved in several key clinical trials for melanoma and for other tumors. His recent research has focused on immunity-related aspects of the tumor microenvironment as it relates to predicting response to immunotherapy.
Sessions as a Speaker
Flagship Lunch @ UCSF: Provocative issues in cancer — immunotherapy, when not to treat, global cancer burden
29 October 2017
12:30 pm – 1:45 pm
- UCSF Mission Bay Campus